Research and Markets: World Market for Clinical Laboratory Instrumentation, Reagents and Supplies for Performing Tumor Marker Tests Analysed
Research and Markets ( http://www.researchandmarkets.com/reports/c1531 ) has announced the addition of Cancer Diagnostic Testing World Markets to their offering
This report describes the specific segment of the in vitro diagnostics market called tumor marker testing. It examines those clinical measurement devices and their reagents and supplies that are utilized in hospitals, clinics, and doctors’ offices to diagnose and monitor cancer. The emphasis in this report is on those companies and products that are actively developing and marketing clinical laboratory instrumentation and reagents and supplies for performing tumor marker tests on serum.
This report defines the dollar volume of sales, both worldwide and in the U.S., of the cancer diagnostics market, and analyzes the factors which influence the size and the growth of important market segments, with projections through the year 2008.
Described separately is a description of the instruments, reagents and supplies marketed by major companies in this market segment. The report discusses the market size, growth rates, and market components for instruments and reagents, controls, and consumables used in this area. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market. Key corporate players are examined for strategy and new business developments.
The report defines the drivers of the Biotech and Diagnostic Industry and discusses such topics as technological innovation, government funding and diagnostic industry spending, among others. There are in depth analyses of the Global Tumor Marker Testing Market including the U.S., European, and Japanese Tumor Marker Market.
The report includes individual analyses of Clinical Diagnostic Serum Based Cancer Markers and describes the important Organ Specific Blood Tumor Markers for Colon Cancer, Prostate Cancer, Pancreatic Cancer, Breast Cancer and Ovarian Cancer, as well as many additional clinically important tests. Also the methods for measuring tumor markers in the routine clinical laboratory are reviewed along with the instruments of the major manufacturers. Companies entering the cancer diagnostics market with novel technology platforms are also reviewed.
There is also an important discussion of the new technologies for cancer diagnostics and the implications of molecular biology for new diagnostic cancer tests. Emerging new technology areas such as Protein Sequencing, DNA Sequencing and The Human Genome Project are placed into the context of their use in cancer diagnosis.
Market Trends and Forecasts in cancer diagnostics such as Ultrasensitive Cancer Tests, Mergers and Acquisitions of Diagnostic Companies, Population Screening, Rt-pcr, Genetic Tests of Hereditary Cancer Risk and more are reported in detail.
Companies Mentioned Include:
— Affemytrix
— Cytogen
— Diagnocure
— Diagnostic Systems Laboratory
— Dianon Systems
— diaDexus
— Genset
— Matritech
— Nextell
— Oncotech
— Oncogene Science
— Northwest Biotherapeutics
— Procyon Bio Pharma
— Urogenesys
— Dianon (Urocore)
— Mitsubishi Kagaku Medical
— EXACT Sciences Corp.
For more information visit http://www.researchandmarkets.com/reports/c1531
